Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
OrthopedicSpinal Implant

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786450

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786450

DLIF and XLIF Implants

PUBLISHED:
PAGES: 278 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global DLIF and XLIF Implants Market to Reach US$1.8 Billion by 2030

The global market for DLIF and XLIF Implants estimated at US$1.5 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 2.6% over the analysis period 2024-2030. Degenerative Disc Diseases Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$821.8 Million by the end of the analysis period. Growth in the Spondylolisthesis Application segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$420.9 Million While China is Forecast to Grow at 5.0% CAGR

The DLIF and XLIF Implants market in the U.S. is estimated at US$420.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$347.6 Million by the year 2030 trailing a CAGR of 5.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Global DLIF and XLIF Implants Market - Key Trends & Drivers Summarized

Is the Rise of Minimally Invasive Spine Surgeries Fueling the Demand for DLIF and XLIF Implants?

Over the past decade, the field of spine surgery has witnessed a significant paradigm shift, with growing clinical and patient preference for minimally invasive surgical (MIS) techniques. Among the most transformative innovations are Direct Lateral Interbody Fusion (DLIF) and Extreme Lateral Interbody Fusion (XLIF), which allow surgeons to access the lumbar spine through a lateral approach rather than the traditional anterior or posterior route. These procedures are designed to minimize damage to muscles and tissues, reduce intraoperative blood loss, shorten hospital stays, and enable faster patient recovery. The increasing popularity of these techniques is largely driven by the global rise in spinal disorders, especially among the aging population. Conditions such as lumbar degenerative disc disease, spondylolisthesis, and spinal stenosis are becoming more prevalent as people live longer and maintain active lifestyles well into old age. DLIF and XLIF implants, which play a central role in stabilizing and realigning the spine during these procedures, are gaining momentum due to their ability to facilitate successful fusions with minimal patient morbidity. Hospitals and ambulatory surgical centers are also investing in equipment and training that support these techniques, reflecting a broader institutional commitment to less invasive care models. Surgeons are increasingly drawn to these approaches not only for their clinical benefits but also for improved workflow and reduced surgical times. Moreover, these implants are often used in combination with cutting-edge intraoperative neuromonitoring and imaging guidance, enhancing surgical accuracy and reducing the risk of complications. As medical professionals continue to adopt and refine these techniques, the demand for DLIF and XLIF implants is expected to grow steadily, making them integral to the future of spinal fusion surgeries.

How Are Innovations in Implant Materials Shaping Market Dynamics?

Material science is at the forefront of innovation in the DLIF and XLIF implants market, with new compositions and structural advancements significantly enhancing implant performance and patient outcomes. Traditionally, titanium was the material of choice due to its strength and biocompatibility, but its radiopaque nature made post-surgical imaging more difficult. This has led to a shift toward materials such as PEEK (polyether ether ketone), which offers radiolucency, allowing for easier post-operative assessments of bone fusion. Furthermore, PEEK's elastic modulus closely matches that of natural bone, reducing stress shielding and promoting healthier bone remodeling. In recent years, porous titanium and hybrid materials combining PEEK and titanium have gained popularity due to their ability to balance visibility, osteointegration, and structural integrity. Another groundbreaking development is the use of 3D printing technology to manufacture implants with customized porous architecture that mimics cancellous bone, which encourages natural bone in-growth. These additively manufactured implants can also be tailored to patient-specific anatomical requirements, improving fit and reducing the risk of complications. Additionally, many companies are incorporating surface treatments such as nano-texturing and bioactive coatings that enhance cell adhesion and accelerate osseointegration. These innovations reduce fusion time and increase the long-term success of spinal procedures. As implant designs continue to evolve, there is a growing focus on multi-functional implants that not only provide mechanical stability but also deliver biological benefits. Clinical studies have begun to document superior outcomes with these advanced materials, influencing purchasing decisions at hospitals and surgical centers. This technological leap is also being fueled by collaborations between material scientists, biomedical engineers, and orthopedic surgeons who are working together to push the boundaries of what implants can achieve in modern spine care.

Are Shifting Healthcare Infrastructures and Reimbursement Policies Altering Market Accessibility?

The global landscape of healthcare delivery is undergoing profound changes, and these shifts are significantly impacting the adoption of DLIF and XLIF implants. In developed nations such as the United States, Germany, and Japan, the presence of well-established healthcare infrastructure and comprehensive insurance coverage has enabled rapid integration of these implants into routine surgical practice. In the U.S., favorable reimbursement policies under Medicare and private insurers have encouraged hospitals to invest in the specialized training and equipment necessary for DLIF and XLIF procedures. This financial support has made it feasible for even mid-sized healthcare facilities to adopt these advanced techniques. Conversely, in emerging markets across Asia, Latin America, and parts of the Middle East, healthcare systems are at varying stages of development, which can either facilitate or hinder the adoption of these technologies. However, there is a clear trend toward modernization and expansion of healthcare services in these regions. Governments are investing heavily in medical infrastructure, and private hospital chains are proliferating, offering high-end spinal surgeries to a growing middle class. Training programs led by international spine societies and global medtech firms are helping to upskill local surgeons in lateral access fusion techniques, thereby driving market expansion. At the same time, reimbursement models are evolving, with more countries moving toward value-based care that rewards clinical efficacy and cost-efficiency-two hallmarks of DLIF and XLIF. Additionally, the rise of outpatient spinal surgeries, particularly in the U.S. and Western Europe, is accelerating demand for implants that are compatible with shorter, less invasive procedures. The increased focus on bundled payments and episode-based reimbursements is also encouraging hospitals to choose implant solutions that minimize complications and readmissions. These systemic changes are reshaping access to DLIF and XLIF implants, democratizing their availability and expanding their role in the global spine surgery ecosystem.

What’s Truly Powering the Market Expansion for DLIF and XLIF Implants?

The growth in the DLIF and XLIF implants market is driven by several factors that are deeply tied to innovation, demographic shifts, surgical evolution, and end-user expectations. One of the most significant drivers is the increasing prevalence of degenerative spinal conditions and trauma-induced injuries, which are fueling the need for effective and reliable spinal fusion procedures. DLIF and XLIF techniques, known for their minimally invasive nature, are becoming the procedures of choice in these scenarios, and the implants used in them are in growing demand. Technological progress in surgical navigation, robotic assistance, and intraoperative imaging is another critical factor; these tools allow for highly precise implant placement, thereby improving clinical outcomes and surgeon confidence. Equally important is the shift in surgical preferences-orthopedic surgeons and neurosurgeons are increasingly favoring lateral approaches due to their ability to avoid major muscle disruption and reduce hospital stays. On the patient side, there is a rising demand for surgeries that allow quicker recovery, less pain, and minimal scarring, all of which DLIF and XLIF procedures promise when paired with the right implants. The expanding trend of ambulatory surgical centers (ASCs) and same-day discharge options is also fueling demand for implants that support short-duration, high-efficiency procedures. Furthermore, the entry of startups and established medtech companies into this niche is intensifying R&D efforts, leading to more diverse and advanced product offerings tailored for specific patient groups, spinal pathologies, and surgeon preferences. Market players are also focusing on strategic collaborations with hospitals and research institutions to create comprehensive procedural ecosystems that integrate implants, instruments, navigation tools, and training modules. These synergies are streamlining the surgical process and creating value for healthcare providers. Lastly, the growing emphasis on data-driven outcomes and long-term cost-effectiveness is prompting institutions to favor implant systems that demonstrate lower revision rates and better patient satisfaction, cementing the position of DLIF and XLIF implants in the global spinal implants market.

SCOPE OF STUDY:

The report analyzes the DLIF and XLIF Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application, Other Applications); End-Use (Hospitals End-Use, Outpatient Facilities End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Alphatec Holdings, Inc. (ATEC Spine)
  • Aurora Spine Corporation
  • B. Braun Melsungen AG
  • Captiva Spine, Inc.
  • Centinel Spine, LLC
  • CoreLink, LLC
  • Curiteva
  • DePuy Synthes (Johnson & Johnson)
  • Exactech, Inc.
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Life Spine, Inc.
  • LDR Holding Corporation
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osseus Fusion Systems
  • RTI Surgical Holdings, Inc.
  • SeaSpine Holdings Corporation
  • Spinal Elements, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP30553

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • DLIF and XLIF Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Minimally Invasive Spine Surgeries Throws the Spotlight on DLIF and XLIF Implant Demand
    • Rising Geriatric Population Propels Growth of Lateral Interbody Fusion Procedures
    • Increasing Adoption of Outpatient and Same-Day Spine Surgeries Strengthens Business Case for Minimally Invasive Implants
    • Advancements in 3D-Printed Implant Designs Expand Addressable Market Opportunity for Patient-Specific Solutions
    • Integration with Robotic and Navigation Systems Drives Adoption in High-Precision Surgical Environments
    • Emergence of Biocompatible and Osteoinductive Materials Accelerates Demand for Next-Gen Implant Platforms
    • Shift Toward Value-Based Healthcare Models Spurs Demand for Clinically Effective and Cost-Efficient Implant Solutions
    • Rising Prevalence of Degenerative Disc Disorders Generates Sustained Need for Fusion-Based Therapeutic Interventions
    • Increasing Preference for Lateral Access Approaches Over Traditional Methods Drives Market Realignment
    • Expanding Surgeon Training and Educational Initiatives Sustain Growth in Procedural Volumes
    • Growing Use of AI and Machine Learning in Surgical Planning Tools Enhances Appeal of Implant-Supported Procedures
    • Demand for Shorter Hospital Stays and Quicker Recovery Times Spurs Shift Toward Minimally Invasive Implant Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DLIF and XLIF Implants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DLIF and XLIF Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Degenerative Disc Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Degenerative Disc Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Degenerative Disc Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spondylolisthesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Spondylolisthesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Spondylolisthesis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Scoliosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Scoliosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Scoliosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Outpatient Facilities End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for DLIF and XLIF Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for DLIF and XLIF Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for DLIF and XLIF Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for DLIF and XLIF Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!